India to United States Bhasma Export Trade Data & Analysis

Name: India to United States Bhasma Bilateral Export Data — 4 Suppliers, 5 Buyers, $10.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z

TransData Nexus

India → United States Corridor Intelligence

India → United States trade corridor intelligence

1Live Corridor Intelligence

The India-U.S. pharmaceutical corridor has experienced stable shipping conditions in recent years. Sea freight from India to the U.S. typically takes approximately 30 days, while air freight averages around 7 days. The majority of shipments are transported by sea, with a smaller proportion by air. Freight rates have remained relatively consistent, though fluctuations can occur due to global economic factors. Currency exchange rates between the Indian Rupee and the U.S. Dollar have shown moderate volatility, impacting the landed cost of products.

2Geopolitical & Sanctions Impact

Geopolitical factors, including trade policies and international relations, can influence the India-U.S. pharmaceutical trade corridor. While there are currently no significant sanctions or trade restrictions affecting this trade route, global conflicts and political developments can impact shipping routes and insurance premiums. Importers should stay informed about international events that may affect the supply chain.

3Trade Agreement & Policy Analysis

There is no Free Trade Agreement (FTA) between India and the United States. Trade between the two countries is governed by World Trade Organization (WTO) rules. Bilateral meetings and trade facilitation measures are ongoing to enhance trade relations, but no significant policy changes have been implemented in the past 18 months.

4Landed Cost Breakdown

The landed cost for importing finished pharmaceutical formulations containing Bhasma from India to the United States includes several components:

FOB (Free on Board) Price: The cost of the product at the point of departure in India.

Freight Charges: Costs associated with transporting the goods from India to the U.S.

Insurance: Coverage for potential damages or losses during transit.

Customs Duty: The U.S. imposes a 0% MFN duty on these products.

Customs Clearance Fees: Charges for processing the goods through U.S. customs.

VAT/GST: Applicable state taxes upon entry into the U.S.

Distribution Costs: Expenses related to warehousing and delivering the product to the final destination.

Per-unit estimates for these costs vary based on factors such as order volume, shipping method, and current market rates.

India → United States corridor analysisApr 2026

United States Pharmaceutical Import Regulations

US FDA registration, GMP, and compliance requirements for Indian exporters

1US FDA Registration & Import Requirements

To import finished pharmaceutical formulations containing Bhasma into the United States, Indian manufacturers must comply with the FDA's stringent regulations. These products are typically classified as drugs and must undergo the FDA's New Drug Application (NDA) process, demonstrating safety and efficacy through clinical trials. The application should be submitted in the Common Technical Document (CTD) format, which includes modules on administrative information, quality, non-clinical study reports, and clinical study reports. The FDA's review timeline for NDAs is generally 10 months, but this can vary based on the application's complexity. Fees associated with the NDA process are substantial and subject to annual adjustments. Additionally, Indian manufacturing facilities must be registered with the FDA and are subject to inspections to ensure compliance with Good Manufacturing Practice (GMP) standards. These inspections assess the facility's adherence to quality control, sanitation, and record-keeping requirements. It's crucial for manufacturers to ensure that their products meet the FDA's standards to avoid import refusals.

2Quality & GMP Standards for Indian Exporters

Indian exporters aiming to supply finished pharmaceutical formulations containing Bhasma to the U.S. must adhere to the FDA's GMP standards. These standards encompass quality control, sanitation, and record-keeping requirements. Manufacturing facilities must be registered with the FDA and are subject to inspections to ensure compliance. Non-compliance can result in import refusals.

United States Bhasma Market Context & Tariffs

Market size, import duties, and competitive landscape · MFN tariff: 0%

1United States Bhasma Market Size & Demand

The U.S. market for Ayurvedic and herbal products, including Bhasma formulations, has been growing steadily. In 2023, India exported over 25% of its Ayurvedic and herbal products to the U.S., indicating a significant demand. The demand is driven by factors such as increasing consumer interest in alternative medicine, a growing aging population, and a focus on holistic health approaches. However, specific market size figures for Bhasma formulations in the U.S. are not readily available.

2Import Tariff & Duty Structure

Finished pharmaceutical formulations containing Bhasma are classified under HS Code 30049011. The U.S. imposes a Most Favored Nation (MFN) import duty of 0% on these products. There are no preferential rates, Free Trade Agreement (FTA) benefits, or exemptions applicable to this product category. Importers should also be aware of potential additional costs, such as customs processing fees and state-specific taxes.

3Competitive Landscape

India is a primary supplier of Ayurvedic products, including Bhasma formulations, to the U.S. market. Other countries, such as China and certain European nations, also export Ayurvedic products to the U.S., but India's market share remains significant. Pricing for Bhasma formulations from India is competitive, though exact figures vary. Quality perceptions are influenced by factors such as adherence to GMP standards and product authenticity. Regulatory acceptance in the U.S. is contingent upon compliance with FDA requirements, which can be a barrier for some suppliers.

Why Source Bhasma from India for United States?

Manufacturing advantage, cost comparison, supply reliability, and strategic sourcing recommendations

1Why India for Bhasma — Manufacturing Advantage

India is a global leader in the production of Ayurvedic products, including Bhasma formulations. The country offers a vast manufacturing scale, cost advantages, and a rich tradition of Ayurvedic medicine. Many Indian facilities are approved by the FDA and adhere to WHO-GMP standards, ensuring high-quality products. This combination of factors makes India a preferred sourcing destination for Bhasma formulations.

2India vs. China vs. EU — Cost & Quality Comparison

When comparing India, China, and the European Union (EU) for sourcing Bhasma formulations, India offers competitive pricing and a strong reputation for quality. Chinese suppliers may offer lower prices but could face challenges related to regulatory acceptance in the U.S. EU suppliers often provide high-quality products but at higher costs. India's adherence to FDA and WHO-GMP standards positions it favorably in terms of both cost and quality.

3Supply Reliability & Capacity Assessment

The India-U.S. supply chain for Bhasma formulations is generally reliable, with established shipping routes and consistent manufacturing capacity. Indian manufacturers have a track record of meeting international demand and maintaining quality standards. However, potential disruptions can occur due to global events, so it's advisable for importers to monitor the situation and maintain open communication with suppliers.

Supplier Due Diligence Guide — Bhasma from India

Pre-qualification checklist, document requirements, red flags, and audit guidance for United States buyers

1Pre-Qualification Checklist for United States Buyers

1FDA Registration: Verify that the Indian manufacturer is registered with the FDA.
2GMP Certification: Ensure the manufacturer holds valid GMP certificates from recognized authorities.
3Drug Master File (DMF): Confirm the manufacturer has an active DMF filed with the FDA.
4Product Testing: Review results from third-party testing for quality and safety.
5Regulatory

Supplier qualification guidance for United States pharmaceutical buyers

Frequently Asked Questions — India to United States Bhasma Trade

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which Indian companies export Bhasma to United States?

The leading Indian exporters of Bhasma to United States are BHARATH VAIDYASALA, GARRY N SUN ORGANICS PRIVATE LIMITED, SHRI KRISHNA ASSOCIATES & CO. BHARATH VAIDYASALA holds the largest market share at approximately 66% of total trade value on this route.

Q What is the total value of Bhasma exports from India to United States?

India exports Bhasma to United States worth approximately $10.3K USD across 18 recorded shipments. The average value per shipment is $570 USD.

Q Which ports does India use to ship Bhasma to United States?

The most active port of origin is COCHIN SEA with 5 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 20% by air.

Q How long does shipping take from India to United States for Bhasma?

The average transit time for Bhasma shipments from India to United States is approximately 30 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October-December.

Q Is the India to United States Bhasma trade route growing?

Yes — this trade corridor has seen an annual growth rate of approximately 24.3% with demand growth tracking at 22.4%. The route is ranked #5 among India's top Bhasma export destinations globally.

Official References & Regulatory Resources

Research Methodology & Data Transparency

SS

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Rank	Supplier (Indian Exporter)	Shipments	Total Value (USD)	Market Share
1	BHARATH VAIDYASALA Avg $681 per shipment	10	$6.8K	66.3%
2	GARRY N SUN ORGANICS PRIVATE LIMITED Avg $775 per shipment	2	$1.6K	15.1%
3	SHRI KRISHNA ASSOCIATES & CO Avg $408 per shipment	3	$1.2K	11.9%
4	AVEDA AYUR LLP Avg $227 per shipment	3	$682	6.6%

Rank	Importer / Buyer	Shipments	Import Value (USD)	Market Share
1	SANTHIGRAM KERALA AYURVEDIC CO OF	9	$6.7K	65.1%
2	GARRY N SUN USA INC	2	$1.6K	15.1%
3	AYURYOGA.INC.	3	$1.2K	11.9%
4	GARRY N SUN USA	3	$682	6.6%
5	SANTHIGRAM KERALA AYURVEDIC	1	$122	1.2%

Rank	Product Formulation	Shipments	Trade Value (USD)	Market Share
1	AYURVEDA PRODUCTS - ABHRAKABHASMAM CAP	1	$1.7K	16.3%
2	GODANTI BHASMA BATCH NO GNSO1110 MFG YEAR MAR 25 EXP YEAR FEB 28	2	$1.6K	15.1%
3	Ayurvedic ARTICLE / ODS / PRODUCT / ITEM - ABHRAKABHASMAM CAP	1	$1.1K	10.9%
4	AYURVEDIC PRODUCTS - SHANKABHASMAM CAPNOS	1	$818	8.0%
5	AYURVEDA PRODUCTS - SHANKABHASMAM CAP	1	$768	7.5%
6	Ayurvedic Herbal Body Massage Oils & Ayurvedic Herbal Supplements- Pravala Bhasma	1	$700	6.8%
7	AYURVEDIC PRODUCTS - SHRINGABHASMAM CAPNOS	1	$679	6.6%
8	AYURVEDA PRODUCTS - SHRINGA BHASMAM CAPSULE	1	$512	5.0%
9	AYURVEDIC ITEMS - SHANKH BHASMA	2	$488	4.8%
10	Ayurvedic ARTICLE / ODS / PRODUCT / ITEM - SHANKABHASMA CAP	1	$482	4.7%

Bhasma

Route Intelligence Overview

Route Characteristics

Bhasma

Route Intelligence Overview

Route Characteristics

Market Position

Top 10 Indian Bhasma Exporters to United States

Top 10 Bhasma Importers in United States

Top 10 Bhasma Formulations Imported by United States

Shipping & Logistics Analysis

Freight Mode Distribution

Top Ports of Origin

Market Dynamics

Route Statistics

Related Analysis

Other Bhasma Routes

Need Details?

Unlock the Full India to United States Bhasma Dataset